FDA-cleared for the treatment of depression†, EXOMIND’s patented ExoTMS™ technology gently stimulates key brain regions responsible for emotional regulation, cognitive performance, and self-control. By activating targeted neural pathways, it supports healthier brain activity and strengthens neural connectivity.